Alkaline 0 8 0 8 B-clinical_variable
phosphatase 9 20 9 20 I-clinical_variable
= 21 22 21 22 O
< 22 23 22 23 O
2.5 24 27 24 27 B-upper_bound
x 28 29 28 29 I-upper_bound
ULN 30 33 30 33 I-upper_bound

Any 0 3 34 37 O
concurrent 4 14 38 48 O
malignancy 15 25 49 59 B-cancer

Any 0 3 60 63 O
significant 4 15 64 75 O
concurrent 16 26 76 86 O
disease 27 34 87 94 O
, 34 35 94 95 O
illness 36 43 96 103 O
, 43 44 103 104 O
or 45 47 105 107 O
psychiatric 48 59 108 119 B-chronic_disease
disorder 60 68 120 128 I-chronic_disease
that 69 73 129 133 O
would 74 79 134 139 O
compromise 80 90 140 150 O
patient 91 98 151 158 O
safety 99 105 159 165 O
or 106 108 166 168 O
compliance 109 119 169 179 O
, 119 120 179 180 O
interfere 121 130 181 190 O
with 131 135 191 195 O
consent 136 143 196 203 O
, 143 144 203 204 O
study 145 150 205 210 O
participation 151 164 211 224 O
, 164 165 224 225 O
follow 166 172 226 232 O
up 173 175 233 235 O
, 175 176 235 236 O
or 177 179 237 239 O
interpretation 180 194 240 254 O
of 195 197 255 257 O
study 198 203 258 263 O
results 204 211 264 271 O

Aspartate 0 9 272 281 B-clinical_variable
transaminase 10 22 282 294 I-clinical_variable
( 23 24 295 296 I-clinical_variable
AST 24 27 296 299 I-clinical_variable
) 27 28 299 300 I-clinical_variable
or 29 31 301 303 O
alanine 32 39 304 311 B-clinical_variable
transaminase 40 52 312 324 I-clinical_variable
( 53 54 325 326 I-clinical_variable
ALT 54 57 326 329 I-clinical_variable
) 57 58 329 330 I-clinical_variable
= 59 60 331 332 O
< 60 61 332 333 O
2.5 62 65 334 337 B-upper_bound
x 66 67 338 339 I-upper_bound
ULN 68 71 340 343 I-upper_bound

Current 0 7 344 351 O
concomitant 8 19 352 363 O
chemotherapy 20 32 364 376 B-treatment
, 32 33 376 377 O
radiation 34 43 378 387 B-treatment
therapy 44 51 388 395 I-treatment
, 51 52 395 396 O
or 53 55 397 399 O
immunotherapy 56 69 400 413 B-treatment
other 70 75 414 419 O
than 76 80 420 424 O
as 81 83 425 427 O
specified 84 93 428 437 O
in 94 96 438 440 O
the 97 100 441 444 O
protocol 101 109 445 453 O

Eastern 0 7 454 461 B-clinical_variable
Cooperative 8 19 462 473 I-clinical_variable
Oncology 20 28 474 482 I-clinical_variable
Group 29 34 483 488 I-clinical_variable
( 35 36 489 490 I-clinical_variable
ECOG 36 40 490 494 I-clinical_variable
) 40 41 494 495 I-clinical_variable
performance 42 53 496 507 I-clinical_variable
status 54 60 508 514 I-clinical_variable
= 61 62 515 516 O
< 62 63 516 517 O
2 64 65 518 519 B-upper_bound

Female 0 6 520 526 B-gender
patients 7 15 527 535 I-gender
of 16 18 536 538 O
childbearing 19 31 539 551 O
potential 32 41 552 561 O
must 42 46 562 566 O
have 47 51 567 571 O
a 52 53 572 573 O
negative 54 62 574 582 O
pregnancy 63 72 583 592 B-pregnancy
test 73 77 593 597 O
within 78 84 598 604 O
2 85 86 605 606 B-upper_bound
weeks 87 92 607 612 I-upper_bound
prior 93 98 613 618 I-upper_bound
to 99 101 619 621 O
entering 102 110 622 630 O
this 111 115 631 635 O
study 116 121 636 641 O

Have 0 4 642 646 O
any 5 8 647 650 O
other 9 14 651 656 O
severe 15 21 657 663 O
concurrent 22 32 664 674 O
disease 33 40 675 682 O
, 40 41 682 683 O
or 42 44 684 686 O
have 45 49 687 691 O
a 50 51 692 693 O
history 52 59 694 701 O
of 60 62 702 704 O
serious 63 70 705 712 O
organ 71 76 713 718 B-chronic_disease
dysfunction 77 88 719 730 I-chronic_disease
or 89 91 731 733 O
disease 92 99 734 741 O
involving 100 109 742 751 O
the 110 113 752 755 O
heart 114 119 756 761 O
, 119 120 761 762 O
kidney 121 127 763 769 O
, 127 128 769 770 O
liver 129 134 771 776 O
, 134 135 776 777 O
or 136 138 778 780 O
other 139 144 781 786 O
organ 145 150 787 792 O
system 151 157 793 799 O
that 158 162 800 804 O
may 163 166 805 808 O
place 167 172 809 814 O
the 173 176 815 818 O
patient 177 184 819 826 O
at 185 187 827 829 O
undue 188 193 830 835 O
risk 194 198 836 840 O
to 199 201 841 843 O
undergo 202 209 844 851 O
treatment 210 219 852 861 B-treatment

Hydroxyurea 0 11 862 873 B-treatment
is 12 14 874 876 O
permitted 15 24 877 886 O
for 25 28 887 890 O
control 29 36 891 898 O
of 37 39 899 901 O
counts 40 46 902 908 O
prior 47 52 909 914 O
to 53 55 915 917 O
treatment 56 65 918 927 B-treatment

No 0 2 928 930 O
prior 3 8 931 936 B-treatment
intensive 9 18 937 946 I-treatment
chemotherapy 19 31 947 959 I-treatment
or 32 34 960 962 O
high 35 39 963 967 B-treatment
- 39 40 967 968 I-treatment
dose 40 44 968 972 I-treatment
cytarabine 45 55 973 983 I-treatment
( 56 57 984 985 O
> 57 58 985 986 O
= 58 59 986 987 O
1 60 61 988 989 B-lower_bound
g 62 63 990 991 I-lower_bound
/ 63 64 991 992 I-lower_bound
m^2 64 67 992 995 I-lower_bound
) 67 68 995 996 O

Off 0 3 997 1000 O
chemotherapy 4 16 1001 1013 B-treatment
for 17 20 1014 1017 O
2 21 22 1018 1019 B-upper_bound
weeks 23 28 1020 1025 I-upper_bound
prior 29 34 1026 1031 I-upper_bound
to 35 37 1032 1034 O
entering 38 46 1035 1043 O
this 47 51 1044 1048 O
study 52 57 1049 1054 O
with 58 62 1055 1059 O
no 63 65 1060 1062 O
toxic 66 71 1063 1068 O
effects 72 79 1069 1076 O
of 80 82 1077 1079 O
that 83 87 1080 1084 O
therapy 88 95 1085 1092 O
, 95 96 1092 1093 O
unless 97 103 1094 1100 O
there 104 109 1101 1106 O
is 110 112 1107 1109 O
evidence 113 121 1110 1118 O
of 122 124 1119 1121 O
rapidly 125 132 1122 1129 O
progressive 133 144 1130 1141 B-chronic_disease
disease 145 152 1142 1149 I-chronic_disease

Pregnant 0 8 1150 1158 B-pregnancy

Prior 0 5 1159 1164 B-treatment
biologic 6 14 1165 1173 I-treatment
therapies 15 24 1174 1183 I-treatment
(= 25 27 1184 1186 O
< 27 28 1186 1187 O
1 29 30 1188 1189 B-upper_bound
cycle 31 36 1190 1195 I-upper_bound
of 37 39 1196 1198 O
prior 40 45 1199 1204 B-treatment
decitabine 46 56 1205 1215 I-treatment
or 57 59 1216 1218 O
azacitidine 60 71 1219 1230 B-treatment
) 71 72 1230 1231 O
, 72 73 1231 1232 O
targeted 74 82 1233 1241 B-treatment
therapies 83 92 1242 1251 I-treatment
, 92 93 1251 1252 O
or 94 96 1253 1255 O
single 97 103 1256 1262 B-treatment
agent 104 109 1263 1268 I-treatment
chemotherapy 110 122 1269 1281 I-treatment
is 123 125 1282 1284 O
allowed 126 133 1285 1292 O

Serum 0 5 1293 1298 B-clinical_variable
bilirubin 6 15 1299 1308 I-clinical_variable
= 16 17 1309 1310 O
< 17 18 1310 1311 O
1.5 19 22 1312 1315 B-upper_bound
x 23 24 1316 1317 I-upper_bound
upper 25 30 1318 1323 I-upper_bound
limit 31 36 1324 1329 I-upper_bound
of 37 39 1330 1332 I-upper_bound
normal 40 46 1333 1339 I-upper_bound
( 47 48 1340 1341 I-upper_bound
ULN 48 51 1341 1344 I-upper_bound
) 51 52 1344 1345 I-upper_bound

Serum 0 5 1346 1351 B-clinical_variable
creatinine 6 16 1352 1362 I-clinical_variable
= 17 18 1363 1364 O
< 18 19 1364 1365 O
1.5 20 23 1366 1369 B-upper_bound
mg 24 26 1370 1372 I-upper_bound
/ 26 27 1372 1373 I-upper_bound
dL 27 29 1373 1375 I-upper_bound

Use 0 3 1376 1379 O
of 4 6 1380 1382 O
investigational 7 22 1383 1398 B-treatment
agents 23 29 1399 1405 I-treatment
within 30 36 1406 1412 O
30 37 39 1413 1415 B-upper_bound
days 40 44 1416 1420 I-upper_bound
or 45 47 1421 1423 O
any 48 51 1424 1427 O
anticancer 52 62 1428 1438 B-treatment
therapy 63 70 1439 1446 I-treatment
within 71 77 1447 1453 O
2 78 79 1454 1455 B-upper_bound
weeks 80 85 1456 1461 I-upper_bound
prior 86 91 1462 1467 I-upper_bound
to 92 94 1468 1470 O
entering 95 103 1471 1479 O
this 104 108 1480 1484 O
study 109 114 1485 1490 O
with 115 119 1491 1495 O
the 120 123 1496 1499 O
exception 124 133 1500 1509 O
of 134 136 1510 1512 O
hydroxyurea 137 148 1513 1524 B-treatment

Women 0 5 1525 1530 B-gender
who 6 9 1531 1534 O
are 10 13 1535 1538 O
able 14 18 1539 1543 O
to 19 21 1544 1546 O
become 22 28 1547 1553 B-pregnancy
pregnant 29 37 1554 1562 I-pregnancy
and 38 41 1563 1566 O
men 42 45 1567 1570 O
who 46 49 1571 1574 O
can 50 53 1575 1578 O
father 54 60 1579 1585 O
a 61 62 1586 1587 O
child 63 68 1588 1593 O
must 69 73 1594 1598 O
use 74 77 1599 1602 B-contraception_consent
birth 78 83 1603 1608 I-contraception_consent
control 84 91 1609 1616 I-contraception_consent
while 92 97 1617 1622 O
on 98 100 1623 1625 O
study 101 106 1626 1631 O
and 107 110 1632 1635 O
for 111 114 1636 1639 O
at 115 117 1640 1642 O
least 118 123 1643 1648 O
8 124 125 1649 1650 B-lower_bound
weeks 126 131 1651 1656 I-lower_bound
after 132 137 1657 1662 I-lower_bound
your 138 142 1663 1667 O
last 143 147 1668 1672 O
dose 148 152 1673 1677 O
of 153 155 1678 1680 O
study 156 161 1681 1686 B-treatment
drug(s 162 168 1687 1693 I-treatment
) 168 169 1693 1694 I-treatment

acceptable 0 10 1695 1705 O
birth 11 16 1706 1711 O
control 17 24 1712 1719 O
includes 25 33 1720 1728 O
a 34 35 1729 1730 O
condom 36 42 1731 1737 B-contraception_consent
or 43 45 1738 1740 O
a 46 47 1741 1742 O
diaphragm 48 57 1743 1752 O
with 58 62 1753 1757 O
spermicidal 63 74 1758 1769 B-contraception_consent
jelly 75 80 1770 1775 I-contraception_consent

higher 0 6 1776 1782 O
risk 7 11 1783 1787 O
MDS 12 15 1788 1791 B-cancer
( 16 17 1792 1793 O
International 17 30 1793 1806 B-clinical_variable
Prognostic 31 41 1807 1817 I-clinical_variable
Scoring 42 49 1818 1825 I-clinical_variable
System 50 56 1826 1832 I-clinical_variable
[ 57 58 1833 1834 I-clinical_variable
IPSS 58 62 1834 1838 I-clinical_variable
] 62 63 1838 1839 I-clinical_variable
int-2 64 69 1840 1845 B-lower_bound
or 70 72 1846 1848 O
high 73 77 1849 1853 O
; 77 78 1853 1854 O
or 79 81 1855 1857 O
> 82 83 1858 1859 O
= 83 84 1859 1860 O
10 85 87 1861 1863 B-lower_bound
% 87 88 1863 1864 I-lower_bound
blasts 89 95 1865 1871 B-clinical_variable
as 96 98 1872 1874 O
defined 99 106 1875 1882 O
by 107 109 1883 1885 O
World 110 115 1886 1891 O
Health 116 122 1892 1898 O
Organization 123 135 1899 1911 O
[ 136 137 1912 1913 O
WHO 137 140 1913 1916 O
] 140 141 1916 1917 O
) 141 142 1917 1918 O

organ 0 5 1919 1924 O
- 5 6 1924 1925 O
confined 6 14 1925 1933 O
prostate 15 23 1934 1942 B-cancer
cancer 24 30 1943 1949 I-cancer
with 31 35 1950 1954 O
no 36 38 1955 1957 O
evidence 39 47 1958 1966 O
of 48 50 1967 1969 O
recurrent 51 60 1970 1979 O
or 61 63 1980 1982 O
progressive 64 75 1983 1994 O
disease 76 83 1995 2002 O
based 84 89 2003 2008 O
on 90 92 2009 2011 O
prostate 93 101 2012 2020 O
- 101 102 2020 2021 O
specific 102 110 2021 2029 O
antigen 111 118 2030 2037 O
( 119 120 2038 2039 O
PSA 120 123 2039 2042 O
) 123 124 2042 2043 O
values 125 131 2044 2050 O
are 132 135 2051 2054 O
also 136 140 2055 2059 O
eligible 141 149 2060 2068 O
for 150 153 2069 2072 O
this 154 158 2073 2077 O
study 159 164 2078 2083 O
if 165 167 2084 2086 O
hormonal 168 176 2087 2095 B-treatment
therapy 177 184 2096 2103 I-treatment
has 185 188 2104 2107 O
been 189 193 2108 2112 O
initiated 194 203 2113 2122 O
or 204 206 2123 2125 O
a 207 208 2126 2127 O
radical 209 216 2128 2135 B-treatment
prostatectomy 217 230 2136 2149 I-treatment
has 231 234 2150 2153 O
been 235 239 2154 2158 O
performed 240 249 2159 2168 O

systemic 0 8 2169 2177 B-chronic_disease
fungal 9 15 2178 2184 I-chronic_disease
, 15 16 2184 2185 O
bacterial 17 26 2186 2195 B-chronic_disease
, 26 27 2195 2196 O
viral 28 33 2197 2202 B-chronic_disease
, 33 34 2202 2203 O
or 35 37 2204 2206 O
other 38 43 2207 2212 O
infection 44 53 2213 2222 B-chronic_disease
not 54 57 2223 2226 O
controlled 58 68 2227 2237 O
( 69 70 2238 2239 O
defined 70 77 2239 2246 O
as 78 80 2247 2249 O
exhibiting 81 91 2250 2260 O
ongoing 92 99 2261 2268 O
signs 100 105 2269 2274 O
/ 105 106 2274 2275 O
symptoms 106 114 2275 2283 O
related 115 122 2284 2291 O
to 123 125 2292 2294 O
the 126 129 2295 2298 O
infection 130 139 2299 2308 O
and 140 143 2309 2312 O
without 144 151 2313 2320 O
improvement 152 163 2321 2332 O
, 163 164 2332 2333 O
despite 165 172 2334 2341 O
appropriate 173 184 2342 2353 O
antibiotics 185 196 2354 2365 B-treatment
or 197 199 2366 2368 O
other 200 205 2369 2374 O
treatment 206 215 2375 2384 B-treatment
) 215 216 2384 2385 O

treated 0 7 2386 2393 O
non 8 11 2394 2397 B-cancer
- 11 12 2397 2398 I-cancer
melanoma 12 20 2398 2406 I-cancer
skin 21 25 2407 2411 I-cancer
cancer 26 32 2412 2418 I-cancer
, 32 33 2418 2419 O
in 34 36 2420 2422 B-cancer
situ 37 41 2423 2427 I-cancer
carcinoma 42 51 2428 2437 I-cancer
, 51 52 2437 2438 O
or 53 55 2439 2441 O
cervical 56 64 2442 2450 B-cancer
intraepithelial 65 80 2451 2466 I-cancer
neoplasia 81 90 2467 2476 I-cancer
, 90 91 2476 2477 O
regardless 92 102 2478 2488 O
of 103 105 2489 2491 O
the 106 109 2492 2495 O
disease 110 117 2496 2503 O
- 117 118 2503 2504 O
free 118 122 2504 2508 O
duration 123 131 2509 2517 O
, 131 132 2517 2518 O
are 133 136 2519 2522 O
eligible 137 145 2523 2531 O
for 146 149 2532 2535 O
this 150 154 2536 2540 O
study 155 160 2541 2546 O
if 161 163 2547 2549 O
definitive 164 174 2550 2560 O
treatment 175 184 2561 2570 B-treatment
for 185 188 2571 2574 O
the 189 192 2575 2578 O
condition 193 202 2579 2588 O
has 203 206 2589 2592 O
been 207 211 2593 2597 O
completed 212 221 2598 2607 O

